1. Home
  2. RGLS vs GIFI Comparison

RGLS vs GIFI Comparison

Compare RGLS & GIFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGLS
  • GIFI
  • Stock Information
  • Founded
  • RGLS 2007
  • GIFI 1985
  • Country
  • RGLS United States
  • GIFI United States
  • Employees
  • RGLS N/A
  • GIFI N/A
  • Industry
  • RGLS Biotechnology: Pharmaceutical Preparations
  • GIFI Metal Fabrications
  • Sector
  • RGLS Health Care
  • GIFI Industrials
  • Exchange
  • RGLS Nasdaq
  • GIFI Nasdaq
  • Market Cap
  • RGLS 102.1M
  • GIFI 115.1M
  • IPO Year
  • RGLS 2012
  • GIFI 1997
  • Fundamental
  • Price
  • RGLS $1.42
  • GIFI $7.13
  • Analyst Decision
  • RGLS Strong Buy
  • GIFI Buy
  • Analyst Count
  • RGLS 6
  • GIFI 1
  • Target Price
  • RGLS $10.33
  • GIFI N/A
  • AVG Volume (30 Days)
  • RGLS 493.3K
  • GIFI 54.5K
  • Earning Date
  • RGLS 11-07-2024
  • GIFI 11-05-2024
  • Dividend Yield
  • RGLS N/A
  • GIFI N/A
  • EPS Growth
  • RGLS N/A
  • GIFI N/A
  • EPS
  • RGLS N/A
  • GIFI 1.05
  • Revenue
  • RGLS N/A
  • GIFI $166,333,000.00
  • Revenue This Year
  • RGLS N/A
  • GIFI $12.86
  • Revenue Next Year
  • RGLS N/A
  • GIFI N/A
  • P/E Ratio
  • RGLS N/A
  • GIFI $6.58
  • Revenue Growth
  • RGLS N/A
  • GIFI 14.99
  • 52 Week Low
  • RGLS $1.08
  • GIFI $4.07
  • 52 Week High
  • RGLS $3.79
  • GIFI $7.93
  • Technical
  • Relative Strength Index (RSI)
  • RGLS 41.95
  • GIFI 65.46
  • Support Level
  • RGLS $1.36
  • GIFI $6.70
  • Resistance Level
  • RGLS $1.65
  • GIFI $7.35
  • Average True Range (ATR)
  • RGLS 0.10
  • GIFI 0.46
  • MACD
  • RGLS -0.01
  • GIFI 0.06
  • Stochastic Oscillator
  • RGLS 28.57
  • GIFI 87.18

About RGLS Regulus Therapeutics Inc.

Regulus Therapeutics Inc is a biotechnology company focused on the development of microRNA therapies. MicroRNA therapies target diseases such as cancer, metabolic diseases, fibrosis, and inflammatory diseases. The product candidate of the company is RGLS8429, an anti-miR next-generation oligonucleotide targeting miR-17 for the treatment of autosomal dominant polycystic kidney disease (ADPKD), and is in Phase 1b clinical development.

About GIFI Gulf Island Fabrication Inc.

Gulf Island Fabrication Inc is a U.S. based company that is a fabricator of complex steel structures and marine vessels. The company also provides installation, hook-up, commissioning, repair, and maintenance services with specialized crews. The company operates through segments namely Fabrication division which fabricates structures such as offshore drilling and production platforms and other steel structures for customers in the oil and gas industries; the Shipyards division manufactures newly built and repairs various steel marine vessels in the United States; the Services division provides interconnect piping services on offshore platforms, welding, and inshore structures and also provides maintenance and industrial facilities.

Share on Social Networks: